Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease

Though promoting remyelination in multiple sclerosis (MS) has emerged as a promising therapeutic strategy, it does not address inflammatory signals that continue to induce neuronal damage and inhibit effectiveness of repair mechanisms. Our lab has previously characterized the immunomodulatory tetrap...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Kaitlyn K., Nissen, Jillian C., Pretory, Amanda, Tsirka, Stella E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283261/
https://www.ncbi.nlm.nih.gov/pubmed/30555470
http://dx.doi.org/10.3389/fimmu.2018.02784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283261/
https://www.ncbi.nlm.nih.gov/pubmed/30555470
http://dx.doi.org/10.3389/fimmu.2018.02784

Ejemplares similares